Related Experiment Videos
Translational research in the San Antonio breast cancer SPORE
1Division of Medical Oncology, University of Texas Health Science Center, San Antonio 78284-7884.
Breast Cancer Research and Treatment
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
Breast cancer research and treatment·2017
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.
Breast cancer research and treatment·2012
Systemic mirnas as potential biomarkers for malignancy.
International journal of cancer·2012
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Molecular endocrinology (Baltimore, Md.)·2011
Real-world estrogen receptor alpha 1 (ESR1) testing patterns and results for ER+/HER2- metastatic breast cancer in the United States, 2018-2024.
Breast cancer research and treatment·2026
Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes.
Breast cancer research and treatment·2026
Exploring trop-2-directed ADCs monotherapy and combination therapy in pretreated mTNBC: a real-world study.
Breast cancer research and treatment·2026
Oestrogen receptor testing and initiation of adjuvant endocrine therapy in women with ductal carcinoma in situ: a population-based study.
Breast cancer research and treatment·2026
Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.
Breast cancer research and treatment·2026
Lymphatic vascular aging and age-related bone loss: current status and future perspectives.
Frontiers in immunology·2026
Microbiota-driven metabolic-immune crosstalk in breast cancer.
Frontiers in pharmacology·2026